Sfoglia per Rivista
Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD
2021-01-01 Le Berre, Catherine; Peyrin-Biroulet, Laurent; SPIRIT-IOIBD study, Group; Spinelli, Antonino
Selection of resistant-associated variants to the NS5A inhibitor daclatasvir : revenge of the hepatitis C virus
2013-01-01 Aghemo, A.; Colombo, M.
SERUM BILE ACIDS PROFILING IN IBD PATIENTS TREATED WITH ANTI-TNF
2019-01-01 Roda, G; Porru, E; Katsanos, K; Skamnelos, A; Kyriakidi, K; Christodoulou, D; Caliceti, C; Fiorino, G; Danese, S; Roda, A
SESSILE SERRATED POLYP (SSP) DETECTION RATES IN PATIENTS UNDERGOING AVERAGE RISK SCREENING COLONOSCOPY: META-ANALYSIS OF PUBLISHED LITERATURE
2017-01-01 Desai, M; Nguyen, J; Gupta, N; Parasa, S; Vennelaganti, S; Hassan, C; Repici, A; Sharma, P
A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn’s Disease
2022-01-01 Dunkin, David; Merlino, Francesco; Correale, Carmen; Yeretssian, Garabet; Marinelli, Luciana; Roda, Giulia; Hovhannisyan, Zara; Couri, Ron; Vetrano, Stefania; Mayer, Lloyd; Danese, Silvio
Sofosbuvir Treatment in the Pre and Post Liver Transplantation Phase: The Sooner, the Better
2015-01-01 Aghemo, A; Donato, Mf
Solid gastric emptying before and after subtotal colectomy in patients with slow transit constipation
1999-01-01 Mollen, Rm; Hopman, Wp; Oyen, W; Kuijpers, Hh; Jansen, Jb
Starving the inflamed gut: Angiogenesis blockade as a novel therapeutic approach to experimental colitis
2005-01-01 Danese, S; Sans, M; Spencer, D; Beck, I; Plunkett, M; Donate, F; Campbell, M; West, G; Redline, R; Mazar, A; de la Motte, C; Gasbarrini, A; Levine, A; Fiocchi, C
Statins and Cancer Risk: A Confounded Association
2009-01-01 Bonovas, S; Sitaras, Nm
Step-up and top-down approaches to the treatment of Crohn’s disease: early may already be too late
2008-01-01 Peyrin-Biroulet, L.; Bigard, M. A.; Malesci, A.; Danese, S.
STIMULATION OF CYP450-MEDIATED omega-3 DOCOSAHEXAENOIC ACID (DHA) METABOLISM VIA MFSD2A AS A NOVEL THERAPY FOR INFLAMMATORY BOWEL DISEASE
2017-01-01 Ungaro, F; Tacconi, C; Correale, C; Massimino, L; Corsetto, P; Fonteyne, P; Piontini, A; Calcaterra, F; Della Bella, S; Spinelli, A; Carvello, M; Rizzo, A; Vetrano, S; Fiorino, G; Furfaro, F; Garzarelli, V; Maddipati, Kr; D'Alessio, S; Danese, S
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients who are primary non-responders or intolerant to infliximab: A real life multi-center experience of compassionate use
2008-01-01 Danese, S; Mocciaro, F; Guidi, L; Scribano, Ml; Comberlato, M; Vangeli, M; Pulitano, R; Manca, A; Armuzzi, A; Malesci, A; Prantera, C; Cottone, M
Surveillance of Barrett's Esophagus Post Ablation: Is It Better to Use Jumbo Over Standard Biopsy Forceps?
2016-01-01 Vennelaganti, S; Vennalaganti, P; Duvvuri, A; Lim, D; Jani, B; Repici, A; Ciscato, C; Spaggiari, P; Consolo, P; Di Leo, M; Mathur, S; Porter, J; Ferrara, E; Kennedy, K; Gupta, N; Sharma, P
SWITCHING FROM INFLIXIMAB ORIGINATOR TO CT-P13 IS NOT RELATED TO INCREASED IMMUNOGENICITY IN IBD PATIENTS: A PROSPECTIVE CASE-CONTROL STUDY
2017-01-01 Fiorino, G; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, Mf; Nagore, D; del Rio, L; Pascual, J; Martnez, A; Danese, S
Synchronous Cancerization Increases Metastatic Potential in MSS Colorectal Cancers (CRCs)
2012-01-01 Laghi, L; Fini, L; Basso, G; Bianchi, P; Delconte, G; Roncalli, M; Repici, A; Malesci, A
Systemic chemotherapy and two-stage hepatectomy in patients with extensive bilobar colorectal liver metastases: Perioperative safety and survival
2007-01-01 Chun, Ys; Vauthey, Jn; Ribero, D; Donadon, M; Eng, C; Brown, Td; Chang, Dz; Ho, L; Curley, Sa; Abdalla, Ek
Targeting SMAD7 in Crohn's Disease by Mongersen: Therapeutic Revolution Under Way?
2015-01-01 Danese, S; Fiorino, G; Peyrin-Biroulet, L.
Telaprevir for hepatitis C re-treatment: an open door on a long and winding road.
2010-01-01 Aghemo, A; Colombo, M.
Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach!
2018-01-01 Jaboli, F; Pouillon, L; Bossuyt, P; Danese, S; Peyrin-Biroulet, L
The 5q31/IBD5 risk haplotype determines perianal phenotype in Crohn's disease
2002-01-01 Armuzzi, A; Ahmad, T; De Silva, Ap; Ling, K; Cullen, S; Van Heel, D; Jewell, D
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD | 1-gen-2021 | Le Berre, Catherine; Peyrin-Biroulet, Laurent; SPIRIT-IOIBD study, Group; Spinelli, Antonino | |
| Selection of resistant-associated variants to the NS5A inhibitor daclatasvir : revenge of the hepatitis C virus | 1-gen-2013 | Aghemo, A.; Colombo, M. | |
| SERUM BILE ACIDS PROFILING IN IBD PATIENTS TREATED WITH ANTI-TNF | 1-gen-2019 | Roda, G; Porru, E; Katsanos, K; Skamnelos, A; Kyriakidi, K; Christodoulou, D; Caliceti, C; Fiorino, G; Danese, S; Roda, A | |
| SESSILE SERRATED POLYP (SSP) DETECTION RATES IN PATIENTS UNDERGOING AVERAGE RISK SCREENING COLONOSCOPY: META-ANALYSIS OF PUBLISHED LITERATURE | 1-gen-2017 | Desai, M; Nguyen, J; Gupta, N; Parasa, S; Vennelaganti, S; Hassan, C; Repici, A; Sharma, P | |
| A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn’s Disease | 1-gen-2022 | Dunkin, David; Merlino, Francesco; Correale, Carmen; Yeretssian, Garabet; Marinelli, Luciana; Roda, Giulia; Hovhannisyan, Zara; Couri, Ron; Vetrano, Stefania; Mayer, Lloyd; Danese, Silvio | |
| Sofosbuvir Treatment in the Pre and Post Liver Transplantation Phase: The Sooner, the Better | 1-gen-2015 | Aghemo, A; Donato, Mf | |
| Solid gastric emptying before and after subtotal colectomy in patients with slow transit constipation | 1-gen-1999 | Mollen, Rm; Hopman, Wp; Oyen, W; Kuijpers, Hh; Jansen, Jb | |
| Starving the inflamed gut: Angiogenesis blockade as a novel therapeutic approach to experimental colitis | 1-gen-2005 | Danese, S; Sans, M; Spencer, D; Beck, I; Plunkett, M; Donate, F; Campbell, M; West, G; Redline, R; Mazar, A; de la Motte, C; Gasbarrini, A; Levine, A; Fiocchi, C | |
| Statins and Cancer Risk: A Confounded Association | 1-gen-2009 | Bonovas, S; Sitaras, Nm | |
| Step-up and top-down approaches to the treatment of Crohn’s disease: early may already be too late | 1-gen-2008 | Peyrin-Biroulet, L.; Bigard, M. A.; Malesci, A.; Danese, S. | |
| STIMULATION OF CYP450-MEDIATED omega-3 DOCOSAHEXAENOIC ACID (DHA) METABOLISM VIA MFSD2A AS A NOVEL THERAPY FOR INFLAMMATORY BOWEL DISEASE | 1-gen-2017 | Ungaro, F; Tacconi, C; Correale, C; Massimino, L; Corsetto, P; Fonteyne, P; Piontini, A; Calcaterra, F; Della Bella, S; Spinelli, A; Carvello, M; Rizzo, A; Vetrano, S; Fiorino, G; Furfaro, F; Garzarelli, V; Maddipati, Kr; D'Alessio, S; Danese, S | |
| Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients who are primary non-responders or intolerant to infliximab: A real life multi-center experience of compassionate use | 1-gen-2008 | Danese, S; Mocciaro, F; Guidi, L; Scribano, Ml; Comberlato, M; Vangeli, M; Pulitano, R; Manca, A; Armuzzi, A; Malesci, A; Prantera, C; Cottone, M | |
| Surveillance of Barrett's Esophagus Post Ablation: Is It Better to Use Jumbo Over Standard Biopsy Forceps? | 1-gen-2016 | Vennelaganti, S; Vennalaganti, P; Duvvuri, A; Lim, D; Jani, B; Repici, A; Ciscato, C; Spaggiari, P; Consolo, P; Di Leo, M; Mathur, S; Porter, J; Ferrara, E; Kennedy, K; Gupta, N; Sharma, P | |
| SWITCHING FROM INFLIXIMAB ORIGINATOR TO CT-P13 IS NOT RELATED TO INCREASED IMMUNOGENICITY IN IBD PATIENTS: A PROSPECTIVE CASE-CONTROL STUDY | 1-gen-2017 | Fiorino, G; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, Mf; Nagore, D; del Rio, L; Pascual, J; Martnez, A; Danese, S | |
| Synchronous Cancerization Increases Metastatic Potential in MSS Colorectal Cancers (CRCs) | 1-gen-2012 | Laghi, L; Fini, L; Basso, G; Bianchi, P; Delconte, G; Roncalli, M; Repici, A; Malesci, A | |
| Systemic chemotherapy and two-stage hepatectomy in patients with extensive bilobar colorectal liver metastases: Perioperative safety and survival | 1-gen-2007 | Chun, Ys; Vauthey, Jn; Ribero, D; Donadon, M; Eng, C; Brown, Td; Chang, Dz; Ho, L; Curley, Sa; Abdalla, Ek | |
| Targeting SMAD7 in Crohn's Disease by Mongersen: Therapeutic Revolution Under Way? | 1-gen-2015 | Danese, S; Fiorino, G; Peyrin-Biroulet, L. | |
| Telaprevir for hepatitis C re-treatment: an open door on a long and winding road. | 1-gen-2010 | Aghemo, A; Colombo, M. | |
| Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach! | 1-gen-2018 | Jaboli, F; Pouillon, L; Bossuyt, P; Danese, S; Peyrin-Biroulet, L | |
| The 5q31/IBD5 risk haplotype determines perianal phenotype in Crohn's disease | 1-gen-2002 | Armuzzi, A; Ahmad, T; De Silva, Ap; Ling, K; Cullen, S; Van Heel, D; Jewell, D |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile